Biodiversity: using artificial intelligence to better identify areas to protect

Can more species be saved from extinction by using artificial intelligence? A team of researchers, led by SIB Group Leader Daniele Silvestro of the University of Fribourg and University of Gothenburg, has trained a new software package, CAPTAIN, to take account of essential parameters - including financial ones - for an efficient choice of areas to be protected.

The quest for small-molecule cancer immunotherapeutics

If you are working in computer-aided drug design, this in silico talk is for you: SIB Senior Research Scientist Ute Röhrig takes you on a journey to push the boundaries of knowledge around IDO1 and its role in immunotherapy resistance.

The national infrastructure to boost personalized health research is up and running

Connecting researchers from across Switzerland with biomedical data to foster personalized health: this is the aim of the national secure computing network BioMedIT, set up by the SIB in collaboration with ETH Zurich and the University of Basel.

How genomic deletions and duplications affect our health

While most of the human genome is the same across individuals, genomic mishaps such as deletions and duplications can reduce or increase the number of copies of specific genetic fragments. These mishaps are also known as copy-number variations or CNVs...

How asexual reproduction affects the evolution of genomes

The first evidence of the consequences of parthenogenesis – a type of asexual reproduction – on genome evolution is reported in an international study co-led by scientists at UNIL and SIB.

Christophe Dessimoz is appointed Joint Executive Director, succeeding Christine Durinx

SIB announces the departure of Christine Durinx, its Joint Executive Director, at end of March 2022, after eight years at the institute. Christophe Dessimoz, SIB Group Leader at the University of Lausanne and a professor at University College London, has been appointed by the Foundation Council and the Board of Directors as her successor.

Discover the newest resources in SIB’s infrastructure portfolio for the life sciences

SIB’s mission, as per its mandate from the Secretariat for Education, Research and Innovation SERI, is to be a provider of long-term, high-impact infrastructure for the life sciences and the biomedical world.

Venom factories: a surprising molecular convergence, from wasps to snakes

Animals as different as wasps and snakes have adopted surprisingly similar molecular mechanisms to squirt toxins out of their specialized cells. This is revealed by a study led by SIB scientists, who have conducted the first comparative analysis of gene expression profiles of venom glands.